How Much Did Syapse Raise? Funding & Key Investors

Date
March 14, 2025
Syapse

Total amount raised

$137.5 Millions

Latest funding date

07/01/2022

Syapse

Location

Title

LINKEDIN

https://image-fetch.clay-run.workers.dev/?url=https://logo.clearbit.com/syapse.com
Use Clay to find other emails
Status
Verified
Use Clay's email finder to get anyone's work email in seconds.

Syapse has successfully raised significant funding over multiple rounds, attracting a diverse group of investors. The company focuses on providing precision medicine solutions to improve patient outcomes.

Keep reading to explore the intricacies of Syapse's fundraising journey and the investors backing this innovative platform.

What Is Syapse?

Syapse, founded in 2008, is headquartered in San Francisco, California. The company specializes in precision medicine, aiming to improve patient outcomes through data-driven insights.

Founded by Jonathan Hirsch and Eric Schadt, Syapse has grown significantly over the years. The company leverages real-world data to support healthcare providers in delivering personalized care.

With a dedicated team of over 100 employees, Syapse continues to innovate in the field of precision medicine. Their solutions are designed to integrate seamlessly into existing healthcare systems, enhancing the quality of care for patients worldwide.

How Much Funding Has Syapse Raised?

  1. Growth Funding Round
    • Amount Raised: $35 million
    • Date: July 2022
    • Lead Investors: Innovatus Capital Partners
    • Valuation at Round: Not publicly disclosed
    • Motivation Behind the Round: To expand Syapse's focus on providing real-world insights to partners and assist them in improving outcomes for people with cancer.

Syapse has raised a total of $35 million. The current valuation is not publicly disclosed.

Key Investors

  • Innovatus Capital Partners
    • Details: Innovatus Capital Partners is a private investment firm that focuses on creating value through innovative investment strategies. They led the latest funding round for Syapse.
    • Investment Focus Areas: Healthcare, real estate, asset-based lending.
    • Notable Investments: Not publicly disclosed.
  • Ally Bridge Group
    • Details: Ally Bridge Group is a global healthcare-focused investment firm. They have a strong track record in investing in innovative healthcare companies.
    • Investment Focus Areas: Healthcare, life sciences, medical technology.
    • Notable Investments: Not publicly disclosed.
  • Merck Global Health Innovation Fund
    • Details: Merck Global Health Innovation Fund is the corporate venture capital arm of Merck & Co. They invest in companies that align with Merck's strategic interests.
    • Investment Focus Areas: Healthcare innovation, digital health, precision medicine.
    • Notable Investments: Not publicly disclosed.
  • Northpond Ventures
    • Details: Northpond Ventures is a venture capital firm that invests in science and technology companies. They focus on transformative innovations.
    • Investment Focus Areas: Life sciences, healthcare, technology.
    • Notable Investments: Not publicly disclosed.
  • Social Capital
    • Details: Social Capital is a venture capital firm that aims to advance humanity by solving the world's hardest problems. They invest in companies that have a significant impact.
    • Investment Focus Areas: Technology, healthcare, education.
    • Notable Investments: Not publicly disclosed.

What's Next for Syapse?

Syapse stands at the cusp of significant growth opportunities, particularly in the realm of precision oncology. By expanding its focus on providing real-world insights, the company aims to enhance outcomes for cancer patients. Collaborations with community health systems and biopharmaceutical companies are set to drive this mission forward, leveraging data to transform patient care.

Future fundraising appears promising, given the recent $35 million growth funding round led by Innovatus Capital Partners. This influx of capital not only underscores investor confidence but also sets the stage for potential future investments. As Syapse continues to innovate, additional funding rounds could further accelerate its impact in the healthcare sector.

However, challenges such as competition in healthcare technology and regulatory hurdles may arise. Integrating real-world data into clinical practice is complex, requiring robust systems and continuous innovation. Despite these challenges, Syapse's strategic partnerships and focus on precision medicine position it well for future success.

Use Clay to Get Funding Data

Sales professionals, take advantage of Clay's platform to access comprehensive fundraising data on companies like Syapse and gather other critical business insights. Sign up for free today and elevate your sales strategy with the power of data-driven insights.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

Try for free

More Articles